Embracing the Medical Potential of Cannabinoids
July 21, 2017
Initial research into the uses of medical cannabis suggests applications across a range of diseases, but research is needed to realize cannabis’ full medical potential.
1 min read
June 2017
Welcome to the June issue! This month, our cover feature delves into the green rush of cannabinoids, and pharma’s fascination with creating medicines from the cannabis plant. In My View sees experts discuss explosive chemical reactions, extended ANDA approval times, and the upcoming serialization deadlines. We also investigate the story behind the world’s first JAK inhibitor for rheumatoid arthritis, how the trends in small-molecule drugs are affecting outsourcing, the importance of manufacturing strategies in bioprocessing, and what the UK’s Brexit decision means for pharmacovigilance. Plus, we sit down with Elisa Cascade, President of Data Solutions at DrugDev.
Enhancing Endocannabinoid Signaling
June 22, 2017
What does the endocannabinoid system mean for drug discovery and development?
1 min read
Forming a Cannabis Society
June 22, 2017
Roger Pertwee shares the story behind the International Cannabinoid Research Society (ICRS).
1 min read
Remaining (Pharmaco)Vigilant Post-Brexit
June 21, 2017
Pharmacovigilance has become increasingly integrated across the EU, but the Article 50 clock is ticking. A Brexit deal that fails to deliver continued close cooperation between the UK and the EU is not an option for patients.
1 min read
Discovery & Development
Small Molecules
Bioprocessing
Biopharma
Outsourcing
Technology & Manufacturing
The Importance of a Manufacturing Strategy: Lessons Learned with Steve Lam
June 21, 2017
For some companies, bioprocessing is a well-oiled machine. For others, it’s a car crash capable of derailing a product launch by months.
1 min read
Business & Regulation
Business & Trends
Outsourcing
Small Molecules
Formulation
Technology & Manufacturing
The Next Stop for Pharma Outsourcing
June 21, 2017
Increasing consumption and steady innovation will be key trends in the small molecule drug market. But what does this mean in terms of contract manufacturing?
1 min read
The Ups and Downs of Drug Development
June 21, 2017
Pfizer scientists reveal the story behind the world’s first JAK inhibitor for rheumatoid arthritis.
1 min read
A New Dawn for Real Time Characterization?
June 21, 2017
Advanced tools such as surface plasmon resonance offer scientists a deeper understanding of their biotherapeutics – and unlock the potential for better products for patients.
1 min read
Discovery & Development
Small Molecules
Formulation
Regulation & Standards
Business & Trends
Drug Delivery
A View From the Biosynthetic Bridge
June 21, 2017
Regulations in the US make cannabis research highly challenging. Could biosynthetic approaches to cannabinoid production prompt regulators to rethink?
1 min read
Smashing the Stigma with Science
June 21, 2017
Cannabis can be a turn off for investors, but Neil Mahapatra and his investment firm are showing the world that there’s nothing to fear – and much to potentially gain – through a collaboration with Oxford University.
1 min read
Cannabis Complex
June 21, 2017
The cannabis plant contains hundreds of different compounds – and most are difficult to formulate – but if overcoming the complexities means new medicines for unmet needs, it’s worth it.
1 min read
A Career in Cannabinoids
June 21, 2017
The complexities of the cannabis plant have made it a fascinating research target for years. And Roger Pertwee is one of the most prolific researchers in the field.
1 min read
Pharma’s Great Green Rush
June 21, 2017
Cannabinoids – naturally found in cannabis – and the human endocannabinoid system are proving to be an intriguing target for drug discovery. But what is the real value of this ancient medicine?
1 min read
Clinical Data Star
June 21, 2017
Sitting Down With... Elisa Cascade is President, Data Solutions at DrugDev, Philadelphia, USA.
1 min read
Serial Killer?
June 21, 2017
Serialization is more than just adding a number to a box – data management will be the key challenge. And the deadline is fast approaching...
1 min read
Calling for ANDA Action
June 21, 2017
Faster review and approval processes could lower drug costs. Can we axe approval times for abbreviated new drug applications down to three months?
1 min read
When Experiments Go Wrong
June 21, 2017
Laboratory safety is a priority for all. We need to get better at sharing data on hazardous chemical reactions.
1 min read
Business-in-Brief
June 21, 2017
Free cancer drugs, mispackaged contraceptive pills, and antibiotic action... What’s new for pharma in business?
1 min read
A Positive-Sum Game
June 21, 2017
Academics highlight the scale of post-market safety events – and the need to invest in pharmacovigilance
1 min read
What Bad Rep?
June 21, 2017
Does pharma have a poor reputation? It’s not nearly as bad as you might think...
1 min read
Leidenfrost Nanochemistry
June 21, 2017
Scientists fabricate anticancer nanoparticles by recreating deep sea volcano chemistry
1 min read
Nanofluidic PAT
June 21, 2017
Is continuous, real-time analysis of biologics during manufacturing on its way?
1 min read
CLOUD with a Silver Lining
June 21, 2017
A new drug database is already helping to uncover novel combinations
1 min read
Business & Regulation
Small Molecules
Facilities & Equipment
Technology & Manufacturing
Business & Trends
Bringing Down the House
June 21, 2017
Pharma’s guide to construction: plan facility, build facility, demolish facility (before use)...
1 min read
